InfuSystem Holdings, Inc. (NYSE:INFU - Get Free Report) shares rose 2.6% on Wednesday . The company traded as high as $6.30 and last traded at $6.29. Approximately 70,000 shares changed hands during trading, a decline of 40% from the average daily volume of 116,204 shares. The stock had previously closed at $6.13.
Analyst Upgrades and Downgrades
INFU has been the topic of a number of recent analyst reports. Sidoti upgraded shares of InfuSystem to a "strong-buy" rating in a report on Tuesday, March 18th. Wall Street Zen cut shares of InfuSystem from a "strong-buy" rating to a "buy" rating in a research report on Wednesday, May 14th. Finally, B. Riley raised shares of InfuSystem to a "strong-buy" rating in a research report on Thursday, May 8th.
Check Out Our Latest Research Report on InfuSystem
InfuSystem Stock Performance
The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59. The stock's 50-day simple moving average is $5.86 and its 200 day simple moving average is $6.49. The stock has a market capitalization of $132.19 million, a P/E ratio of 104.85 and a beta of 1.81.
Hedge Funds Weigh In On InfuSystem
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Minerva Advisors LLC boosted its position in InfuSystem by 7.5% during the first quarter. Minerva Advisors LLC now owns 910,677 shares of the company's stock worth $4,899,000 after purchasing an additional 63,826 shares during the period. First Eagle Investment Management LLC boosted its position in shares of InfuSystem by 25.9% in the fourth quarter. First Eagle Investment Management LLC now owns 908,371 shares of the company's stock valued at $7,676,000 after acquiring an additional 186,668 shares during the period. Meros Investment Management LP boosted its position in shares of InfuSystem by 2.6% in the fourth quarter. Meros Investment Management LP now owns 631,105 shares of the company's stock valued at $5,333,000 after acquiring an additional 16,178 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of InfuSystem by 5.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 456,043 shares of the company's stock valued at $3,853,000 after acquiring an additional 21,697 shares during the period. Finally, Geode Capital Management LLC boosted its position in shares of InfuSystem by 1.8% in the fourth quarter. Geode Capital Management LLC now owns 444,476 shares of the company's stock valued at $3,756,000 after acquiring an additional 7,968 shares during the period. 71.13% of the stock is owned by institutional investors.
About InfuSystem
(
Get Free Report)
InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider InfuSystem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InfuSystem wasn't on the list.
While InfuSystem currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.